Balance, December 31, 2017. Cumulative adjustment Net earnings Cash dividends paid ($3.54 per share) Employee compensation and stock option plans Repurchase of common stock Other Other comprehensive income (loss), net of tax Balance, December 30, 2018 Net earnings Cash dividends paid ($3.75 per share) Employee compensation and stock option plans Repurchase of common stock Other Other comprehensive income (loss), net of tax Balance, December 29, 2019 Net earnings Cash dividends paid ($3.98 per share) Employee compensation and stock option plans Repurchase of common stock Other Other comprehensive income (loss), net of tax Balance, January 3, 2021 JOHNSON & JOHNSON AND SUBSIDIARIES CONSOLIDATED STATEMENTS OF EQUITY (Dollars in Millions) (Note 1) S S Total 60,160 (486) 15,297 (9,494) 1,949 (5,868) (15) (1.791) 59,752 15,119 (9,917) 1,933 (6,746) (1) (669) 59,471 14,714 (10,481) 2,217 (3,221) (71) 649 63,278 Retained Earnings 101,793 (254) 15,297 (9,49-4) (1,111) (15) 106,216 15,119 (9,917) (758) (1) 110,659 14,714 (10,481) (931) (71) 113,890 Accumulated Other Comprehensive Income (Loss) (13,199) (232) (1,791) (15,222) (669) (15.891) 649 (15,242) Common Stock Issued Amount 3,120 See Note 1 to Consolidated Financial Statements for additional details on the effect of cumulative adjustments to retained earnings Consolidated Financial Statements 3,120 3,120 3,120 Treasury Stock Amount (31,554) 3,060 (5,868) (34,362) 2,691 (6,746) (38,417) 3,148 (3,221) (38,490) JOHNSON & JOHNSON AND SUBSIDIARIES CONSOLIDATED STATEMENTS OF EARNINGS (Dollars and Shares in Millions Except Per Share Amounts) (Note 1) 2020 Sales to customers Cost of products sold Gross profit Selling, marketing and administrative expenses Research and development expense In-process research and development (Note 5). Interest income Interest expense, net of portion capitalized (Note 4) Other (income) expense, net Restructuring (Note 20) Earnings before provision for taxes on income Provision for taxes on income (Note 8) Net earnings Net earnings per share (Notes 1 and 15) Basic Diluted Average shares outstanding (Notes 1 and 15) Basic Diluted Son Notes to Consolidated Financial Statements 82,584 28,427 54,157 22,084 12,159 181 (111) 201 2,899 247 16,497 1,783 14,714 5.59 5.51 2,632.8 2,670.7 2019 82,059 27,556 54,503 22,178 11,355 890 (357) 318 2,525 266 17,328 2,209 15,119 5.72 5.63 2,645.1 2,684.3 2018 81,581 27,091 54,490 22,540 10,775 1,126 (611) 1,005 1,405 251 17,999 2,702 15,297 5.70 5.61 2,681.5 2,728.7 JOHNSON & JOHNSON AND SUBSIDIARIES CONSOLIDATED BALANCE SHEETS At January 3, 2021 and December 29, 2019 (Dollars in Millions Except Share and Per Share Amounts) (Note 1) Assets Current assets Cash and cash equivalents (Notes 1 and 2) Marketable securities (Notes 1 and 2) Accounts receivable trade, less allowances for doubtful accounts $293 (2019, $226) Inventories (Notes 1 and 3) Prepaid expenses and other receivables Assets held for sale (Note 18) Total current assets Property, plant and equipment, net (Notes 1 and 4) Intangible assets, net (Notes 1 and 5) Goodwill (Notes 1 and 5) Deferred taxes on income (Note 8) Other assets Total assets Liabilities and Shareholders' Equity Current liabilities Loans and notes payable (Note 7) Accounts payable Accrued liabilities Accrued rebates, returns and promotions Accrued compensation and employee related obligations Accrued taxes on income (Note 8) Total current liabilities Long-term debt (Note 7) Deferred taxes on income (Note 8) Employee related obligations (Notes 9 and 10) Long-term taxes payable (Note 1) Other liabilities. Total liabilities Commitments and Contingencies (Note 19) Shareholders' equity Preferred stock-without par value (authorized and unissued 2,000,000 shares) Common stock-par value $1.00 per share (Note 12) (authorized 4,320,000,000 shares; issued 3,119,843,000 shares) Accumulated other comprehensive income (loss) (Note 13) Retained earnings Less: common stock held in treasury, at cost (Note 12) (487,331,000 shares and 487,336,000 shares) Total shareholders' equity Total liabilities and shareholders' equity See Notes to Consolidated Financial Statements 2020 13,985 11,200 13,576 9,344 3,132 51,237 18,766 53,402 36,393 8,534 6,562 174,894 2,631 9,505 13,968 11,513 3,484 1,392 42,493 32,635 7,214 10,771 6,559 11,944 111,616 3,120 (15,242) 113,890 101,768 38,490 63,278 174,894 2019 17,305 1,982 14,481 9,020 2,392 94 45,274 17,658 47,643 33,639 7,819 5,695 157,728 1,202 8,544 9,715 10,883 3,354 2,266 35,964 26,494 5,958 10,663 7,444 11,734 98,257 3,120 (15,891) 110,659 97,888 38,417 59,471 157,728 39 Question 15 Save this response. Johnson and Johnson's undistributed earnings at the most recent balance sheet date was (in millions): O a. $14,714 O b. $82,584 O c. $113,890 O d. $63,278 Question 16 The cash dividends amount declared and paid by Johnson and Johnson during the most recent reporting period was $10,481 (in millions). O True False Question 17 Did Johnson and Johnson pay cash to repurchase any of its common stock shares during the most recent reporting period? O a. Yes O b. No Question 18 Which of Johnson and Johnson's financial statements is not accrual-based? O a. Income statement O b. Balance sheet c. Statement of shareholders' equity O d. Statement of cash flows Question 19 For the most recent reporting period, Johnson and Johnson's largest source of cash was from: O a. Investing activities O b. Operating activities O c. Financing activities Question 20 Johnson and Johnson's cash-based net income for the most recent reporting period was (in millions); O a. $14,714 O b. $23,536 O c. $82,584 O d. $13,985 Cash flows from operating activities Net earnings Adjustments to reconcile net earnings to cash flows from operating activities: Depreciation and amortization of property and intangibles Stock based compensation Asset write downs Contingent consideration reversal Net gain on sale of assets/businesses Deferred tax provision Credit losses and accounts receivable allowances Changes in assets and liabilities, net of effects from acquisitions and divestitures: Decrease (Increase) in accounts receivable Increase in inventories Increase in accounts payable and accrued abilities Increase in other current and non current sets Increase (Decrease) in other current and non-current liabilities Net cash flows from operating activities Cash flows from investing activities Additions to property, plant and equipment Proceeds from the disposal of assets/businesses, net Acquisitions, net of cash acquired (Note 18) Purchases of investments Sales of investments Credit support agreements activity, net Other (primarily licenses and milestones) JOHNSON & JOHNSON AND SUBSIDIARIES CONSOLIDATED STATEMENTS OF CASH FLOWS (Dollars in Millions) (Note 1) Net cash used by investing activities Cash flows from financing activities Dividends to shareholders Repurchase of common stock Proceeds from short-term debt Repayment of short-term debt Proceeds from long-term debt, net of issuance costs Repayment of long-term debt Proceeds from the exercise of stock options/employee withholding tax on stock awards, net Credit support agreements activity, net Other Net cash used by financing activities Effect of exchange rate changes on cash and cash equivalents (Decrease Increase in cash and cash equivalents Cash and cash equivalents, beginning of year (Note 1) Cash and cash equivalents, end of year (Note 1) Supplemental cash flow data Cash paid during the year for: Interest Interest, net of amount capitalized Income taxes S 2020 14,714 7,231 1,005 233 (1,148) (111) (1,141) 63 774 (265) 5,141 (3,70-4) 744 23,536 (3,347) 305 (7,323) (21,009) 12,137 (987) (521) (20,825) (10,481) (3,221) 3,391 (2,663) 7,431 (1,064) 1,114 (333) (294) (6,120) 89 (3,320) 17,305 13,985 904 841 4,619 2019 15,119 7,009 977 1,096 (2,154) (2,476) (20) (289) (277) 4,060 (1,054) 1,425 23,416 (3,498) 3,265 (5,810) (3,920) 3,387 338 44 (6,194) (9,917) (6,746) 39 (100) 3 (2,823) 954 100 475 (18,015) (9) (802) 18,107 17,305 995 925 4,191 2018 15,297 6,929 978 1,258 (1,217) (1,016) (1,185) (644) 3,951 (275) (1,844) 22,201 (3,670) 3,203 (899) (5,626) 4,209 (464) (3,167) (9,494) (5,868) 80 (2,479) 5 (1,555) 949 25 (173) (18,510) (241) dars 283 17,824 18,107 1,049 963 4,570